全文获取类型
| 收费全文 | 162篇 |
| 免费 | 11篇 |
专业分类
| 林业 | 7篇 |
| 农学 | 2篇 |
| 2篇 | |
| 综合类 | 13篇 |
| 农作物 | 10篇 |
| 水产渔业 | 11篇 |
| 畜牧兽医 | 115篇 |
| 园艺 | 13篇 |
出版年
| 2021年 | 6篇 |
| 2020年 | 2篇 |
| 2019年 | 11篇 |
| 2018年 | 8篇 |
| 2017年 | 5篇 |
| 2016年 | 3篇 |
| 2015年 | 3篇 |
| 2014年 | 11篇 |
| 2013年 | 6篇 |
| 2012年 | 15篇 |
| 2011年 | 10篇 |
| 2010年 | 6篇 |
| 2009年 | 13篇 |
| 2008年 | 12篇 |
| 2007年 | 13篇 |
| 2006年 | 11篇 |
| 2005年 | 6篇 |
| 2004年 | 6篇 |
| 2003年 | 4篇 |
| 2002年 | 3篇 |
| 2001年 | 7篇 |
| 2000年 | 3篇 |
| 1999年 | 4篇 |
| 1998年 | 4篇 |
| 1993年 | 1篇 |
排序方式： 共有173条查询结果，搜索用时 46 毫秒
31.
AIM: To investigate the clinical characteristics of microRNA (miR)-196b in colorectal cancer (CRC) and to study its biological function in 5-fluorouracil (5-FU) resistance. METHODS: miRNA sequence dataset and the corresponding clinical data of CRC patients were downloaded from The Cancer Genome Atlas (TCGA). Expression level and clinical characteristics of miR-196b in CRC patients were analyzed using SPSS 17.0. CRC cell line overexpres-sing miR-196b was established using transient transfection method. MTS test was used to evaluate the effect of miR-196b overexpression on 5-FU resistance. RESULTS: miR-196b expression was associated with lymph node metastasis and TNM stage (P<0.05), but not related with age and sex. Lymph node metastasis and distant metastasis were independent prognostic factors for rectal patients (P<0.05). The expression level of miR-196b was not associated with survival condition of rectal patients. The viability of the cells overexpressing miR-196b treated with different concentrations of 5-FU was significantly higher than that in control group (P<0.05). CONCLUSION: miR-196b may be a potential biomarker of TNM stage and lymph node metastasis in CRC. miR-196b increases the 5-FU resistance of CRC cells. 相似文献
32.
33.
34.
35.
36.
37.
Axiak SM Carreras JK Hahn KA Endicott MM Parshley DE King GK 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2006,20(6):1398-1401
BACKGROUND: Reports describe the technique and efficacy of half-body irradiation (HBI) of dogs with lymphoma, but few describe the distinctive toxicoses associated with the combination of HBI and chemotherapy. HYPOTHESIS: HBI would transiently affect myelocytic and erythroid variables as assessed by serial analysis of complete blood counts. ANIMALS: Twenty-nine dogs with lymphoma treated with HBI during 2002 and 2003. METHODS: A retrospective study of medical records of 29 dogs was performed. Two HBI protocols were used, resulting in delivery of either 6 Gy or 8 Gy to each half of the body, 1 month apart. Dogs received chemotherapy before, during, or after irradiation, or at multiple times. Serial hematology was available for all dogs. Data were analyzed between collection periods by analysis of variance (ANOVA) RESULTS: The mean granulocyte count significantly (P < .01) decreased from 10,017 cells/microL (data range 3,001-20,170 cells/ microL) before the first radiation treatment to 3,250 cells/microL (820-4,400 cells/microL) at week 5 (P < .01). Three weeks after this nadir, the mean increased to 10,150 cells/microL (900-26,700 cells/microL). The hematocrit did not change (36-38%). Thrombocytopenia (<100,000/microL) occurred in 10 dogs. Two dogs died because of complications associated with thrombocytopenia. No significant difference in toxicity was found between the 6 Gy and 8 Gy group. CONCLUSIONS AND CLINICAL IMPORTANCE: HBI was myelosuppressive but effects were short term and resolved in 22 of 24 dogs. Further studies are needed to elucidate the safety and role of HBI in the treatment of dogs with lymphoma. 相似文献
38.
[目的]探讨三叶悬钩子对体外培养的3种肿瘤细胞的影响。[方法]以不同浓度的三叶悬钩子提取物作用于体外培养的SGC7901(人胃腺癌细胞株)、K562(人红细胞白血病细胞株)及HL60(人早幼粒白血病细胞株),然后以MTT法检测细胞的生长抑制率。[结果]三叶悬钩子氯仿提取物和石油醚提取物均能够抑制SGC7901、K562和HL60细胞的生长,抑制作用随药物浓度的增大而增强。氯仿提取物对SGC7901和K562细胞的半数抑制浓度分别为55.53和28.03μg/ml;石油醚提取物对SGC7901和K562细胞的半数抑制浓度分别为29.52和14.99μg/ml,但这2种提取物对HL60细胞的半数抑制浓度均较大。而不同浓度的氯仿提取物和石油醚提取物对3种肿瘤细胞的抑制率均小于10μg/ml的顺铂。乙酸乙酯提取物、正丁醇提取物及水提取物对3种肿瘤细胞几乎无抑制作用。[结论]三叶悬钩子氯仿提取物和石油醚提取物对体外SGC7901、K562及HL60细胞的生长具有较好的抑制作用。 相似文献
39.
M. Pastor K. Chalvet-Monfray T. Marchal G. Keck J.P. Magnol C. Fournel-Fleury F. Ponce 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2009,23(2):301-310
Background: The etiology of non-Hodgkin's lymphomas (NHL) is multifactorial. Environmental and genetic factors are frequently incriminated both in humans and dogs.
Objectives: Our purpose was to study the geographic distribution of canine NHL (CNHL) in France and to evaluate genetic and environmental influences.
Animals: Six hundred and eight cases of CNHL, diagnosed throughout France over 1 year, were collected from 7 Veterinary Histopathologic Laboratories.
Methods: Retrospective study. Breeds affected by lymphomas were compared with the national population and associations between breed and immunophenotype were studied. The distribution of CNHL and canine T-cell NHL per 100,000 dogs per department was compared with the distribution of waste incinerators, polluted sites, and radioactive waste.
Results: The breeds significantly overrepresented among lymphoma cases were Boxer, Setter, and Cocker Spaniel ( P < .001). There was a significant association between Boxer and T-cell NHL ( P < .001), and between German Shepherd and Rottweiler and B-cell NHL ( P < .01). The geographic distribution of CNHL and canine T-cell NHL indicated significant heterogeneity. Significant association between distributions of CNHL and waste incinerators (ρ= 0.25, P < .05), polluted sites (ρ= 0.36, P < .001), and radioactive waste (ρ= 0.51, P < .001) was found.
Conclusions and Clinical Importance: Influence of genetics in the development of CNHL was supported by the existence of an association between breed and immunophenotype. Waste incinerators, polluted sites, and radioactive waste could just be considered as risk indicators of CNHL, but not as risk factors. Case-control studies around critical sites are necessary to confirm the implication of those environmental factors in the development of CNHL. 相似文献
Objectives: Our purpose was to study the geographic distribution of canine NHL (CNHL) in France and to evaluate genetic and environmental influences.
Animals: Six hundred and eight cases of CNHL, diagnosed throughout France over 1 year, were collected from 7 Veterinary Histopathologic Laboratories.
Methods: Retrospective study. Breeds affected by lymphomas were compared with the national population and associations between breed and immunophenotype were studied. The distribution of CNHL and canine T-cell NHL per 100,000 dogs per department was compared with the distribution of waste incinerators, polluted sites, and radioactive waste.
Results: The breeds significantly overrepresented among lymphoma cases were Boxer, Setter, and Cocker Spaniel ( P < .001). There was a significant association between Boxer and T-cell NHL ( P < .001), and between German Shepherd and Rottweiler and B-cell NHL ( P < .01). The geographic distribution of CNHL and canine T-cell NHL indicated significant heterogeneity. Significant association between distributions of CNHL and waste incinerators (ρ= 0.25, P < .05), polluted sites (ρ= 0.36, P < .001), and radioactive waste (ρ= 0.51, P < .001) was found.
Conclusions and Clinical Importance: Influence of genetics in the development of CNHL was supported by the existence of an association between breed and immunophenotype. Waste incinerators, polluted sites, and radioactive waste could just be considered as risk indicators of CNHL, but not as risk factors. Case-control studies around critical sites are necessary to confirm the implication of those environmental factors in the development of CNHL. 相似文献
40.
B. M. Pressler L. E. Williams J. A. Ramos-Vara K. I. Anderson 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2009,23(3):592-597
Background: Similarities in human and canine renal cell carcinoma (RCC) epidemiology and biologic behavior suggest that molecular mechanisms of tumorigenesis may be similar in both species. Approximately 75% of RCC in people are of the clear cell subtype, up to 85% of which are associated with mutation of the von Hippel-Lindau ( VHL ) gene. The canine VHL coding deoxyribonucleic acid (DNA) shares 90% identity with the human VHL gene.
Objective: To determine whether or not RCC in dogs are associated with VHL mutations, and if so determine the prevalence, type, and location of these mutations.
Animals: Thirteen dogs with RCC, 2 dogs with primary renal sarcomas, and 10 dogs without neoplastic kidney disease.
Methods: DNA was extracted from paraffin-embedded RCC tissue; DNA extracts from paraffin-embedded and snap-frozen nonneoplastic canine kidneys and canine whole blood were used as negative controls. Polymerase chain reaction and sequencing of the 3 VHL exons was performed, and results compared with the accessioned canine sequence.
Results: All VHL exons were amplified from 9 of 13 canine RCC samples, both renal sarcomas, 8 of 10 nonneoplastic kidney samples, and canine whole blood; only exon 2 could be amplified from 2 RCC samples. Mutations were not identified in any exons. A maximal prevalence of 33.6% for VHL mutations in canine RCC was determined.
Conclusion and Clinical Importance: Although similarities between canine and human RCC merit further investigation of the dog as a model for some subtypes of renal tumors, the lower prevalence of VHL mutations suggests that oncogenesis in these 2 species differs. 相似文献
Objective: To determine whether or not RCC in dogs are associated with VHL mutations, and if so determine the prevalence, type, and location of these mutations.
Animals: Thirteen dogs with RCC, 2 dogs with primary renal sarcomas, and 10 dogs without neoplastic kidney disease.
Methods: DNA was extracted from paraffin-embedded RCC tissue; DNA extracts from paraffin-embedded and snap-frozen nonneoplastic canine kidneys and canine whole blood were used as negative controls. Polymerase chain reaction and sequencing of the 3 VHL exons was performed, and results compared with the accessioned canine sequence.
Results: All VHL exons were amplified from 9 of 13 canine RCC samples, both renal sarcomas, 8 of 10 nonneoplastic kidney samples, and canine whole blood; only exon 2 could be amplified from 2 RCC samples. Mutations were not identified in any exons. A maximal prevalence of 33.6% for VHL mutations in canine RCC was determined.
Conclusion and Clinical Importance: Although similarities between canine and human RCC merit further investigation of the dog as a model for some subtypes of renal tumors, the lower prevalence of VHL mutations suggests that oncogenesis in these 2 species differs. 相似文献